Nicholas Reder
Nicholas Reder is Chief Executive Officer at Alpenglow Biosciences. He also serves as an Acting Instructor at the University of Washington and is a member of the Digital and Computational Pathology Committee at the College of American Pathologists.
GeekWire 2026 Innovation of the Year Finalists Include Alpenglow Biosciences and Pacific Northwest National Laboratory
The 2026 GeekWire Awards announced finalists for Innovation of the Year, including Alpenglow Biosciences, Pacific Northwest National Laboratory, RevealDx, Starcloud, and VerAvanti, recognized for breakthroughs in healthcare and data center technology. The awards event will be held on May 7 in Seattle, with public voting open through April 10.
Alpenglow Biosciences Partners with PathNet to Commercialize 3D Microscope Tech for Cancer Diagnostics with $250K Funding
Seattle-based Alpenglow Biosciences partnered with PathNet to commercialize its 3D microscope technology for cancer diagnostics, focusing on prostate and bladder cancers. The startup also secured $250,000 in funding from Mike Rice to support regulatory validation and clinical application development.
Lightspeed Microscopy raises $4M Series A from Dynamk Capital to commercialize 3D pathology imaging platform
Lightspeed Microscopy, a Seattle startup spun out of the University of Washington, raised $4 million in a Series A led by Dynamk Capital to commercialize an end-to-end 3D pathology microscopy platform that optically clears and rapidly scans intact samples, then uses cloud-based AI to produce 3D images for pharma and clinical use.
Organizations
See all 4-
Alpenglow Biosciences CEO, Founder & Co-Inventor 2019–present, Executive Officer, Director 2019–present, Chief Scientific Officer 2018–2019 · current
-
College of American Pathologists (CAP) Digital and Computational Pathology Committee - Member 2020–present, In Vivo Microscopy Committee - Full Member and Chair of Awareness and Education Subcommittee 2019–2020, In VIvo Microscopy Committee - Junior Member 2017–2018 · current
-
University of Washington Acting Instructor 2018–present, Pathology resident and genitourinary pathology fellow 2014–2018 · current
Education
-
Loyola University Chicago Stritch School of Medicine Doctor of Medicine (MD) · 2010–2014
-
Emory University Master of Public Health (MPH), Epidemiology · 2008–2010
-
University of Michigan Bachelor of Science (BS), Biochemistry · 2004–2008
Online
Questions about Nicholas Reder
Who is Nicholas Reder?
Nicholas Reder is CEO, Founder & Co-Inventor at Alpenglow Biosciences.
Which organizations is Nicholas Reder associated with?
On Seattle Flow, Nicholas Reder is listed with Alpenglow Biosciences, College of American Pathologists (CAP), University of Washington and 1 more.
Where did Nicholas Reder study?
Nicholas Reder studied at Loyola University Chicago Stritch School of Medicine, Emory University and University of Michigan.
Where is Nicholas Reder based?
Nicholas Reder is based in Seattle, Washington, United States.